Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Medtronic’s Solitaire Gets STRATIS Real-World Stroke Boost

Executive Summary

Registry data presented at the International Stroke Conference confirm that mechanical thrombectomy with Medtronic’s Solitaire stent retriever can be safely performed in community hospitals as effectively as it was in the randomized trials observed in randomized trials. The results also show that the benefits of transferring a patient with an acute ischemic stroke to a comprehensive stroke center are usually not worth the extra time it takes to transport the patient there.


Related Content

Starts & Stops: Boston Scientific Starts, Stops, And Finishes TAVR Trials





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst